Case Report: Acamprosate Treatment for Volatile Hydrocarbon Inhalant Use Disorder with Comorbid Alcohol Use Disorder

A 39-year-old male with escalating volatile hydrocarbon inhalant use (computer duster) and comorbid alcohol use disorder was treated with acamprosate, a medication approved for alcohol use disorder, based on shared glutamatergic and GABAergic pathways. The case suggests acamprosate may warrant further investigation as a potential pharmacotherapy for inhalant use disorder, an understudied substance use condition.